Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen

Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen

Structural analysis and detection of optimal cell surface localization of labyrinthin, a pan-adenocarcinoma target, was studied with respect to adenocarcinoma specificity vs. normal and non-adenocarcinoma cells. Patient-derived tissue microarray immunohistochemistry (IHC) was performed on 729 commer...

Full description

Bibliographic Details
Main Authors:	Michael Babich, Ankit Sharma, Tianhong Li, James A. Radosevich
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Heliyon
Subjects:	Tumor associated antigen Tumor specific antigen Neoantigen Pan-tumor target Adenocarcinoma ASPH
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844022002766

Similar Items

Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker
by: Ankit Sharma, et al.
Published: (2023-07-01)

Tumor antigens and vaccines in colorectal cancer
by: Zhongen Wu, et al.
Published: (2022-12-01)

Cancer Vaccines: Antigen Selection Strategy
by: Yue Zhao, et al.
Published: (2021-01-01)

CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information Exploration
by: Jijun Yu, et al.
Published: (2022-05-01)

The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy
by: Yae Kye, et al.
Published: (2022-08-01)

A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
by: Robin Minati, et al.
Published: (2020-12-01)

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
by: Lu Diao, et al.
Published: (2023-08-01)

Lack of shared neoantigens in prevalent mutations in cancer
by: Concetta Ragone, et al.
Published: (2024-04-01)

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
by: Belen Aparicio, et al.
Published: (2024-12-01)

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
by: Weiyan Zhang, et al.
Published: (2024-03-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
by: Zheying Zhang, et al.
Published: (2021-04-01)

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses
by: Vitaly Kochin, et al.
Published: (2017-04-01)

Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
by: Ping Zhu, et al.
Published: (2023-06-01)

A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That <i>SEMA7A</i> as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma
by: Yange Wang, et al.
Published: (2022-08-01)

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
by: Noa G. Holtzman, et al.
Published: (2021-12-01)

Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads
by: Adela Kiessling, et al.
Published: (2022-03-01)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
by: Valérie Janelle, et al.
Published: (2020-02-01)

Editorial: Novel Strategies for Anti-Tumor Vaccines
by: Roberto S. Accolla, et al.
Published: (2020-01-01)

Implications of Antigen Selection on T Cell-Based Immunotherapy
by: Faye A. Camp, et al.
Published: (2021-09-01)

Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues
by: Hugo de Jonge, et al.
Published: (2021-02-01)

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)
by: Fang Lv, et al.
Published: (2021-06-01)

Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer
by: Roberto Benelli, et al.
Published: (2020-04-01)

Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates
by: Xinhui Li, et al.
Published: (2022-11-01)

Tumor-Associated Granulomas Preceding a Diagnosis of Thoracic Sarcoidosis: A Retrospective, Single-Center Cohort Study
by: Patricia Muñoz-Hernández, et al.
Published: (2021-09-01)

Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
by: Tomoyo Shinkawa, et al.
Published: (2021-01-01)

CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
by: Anna Christina Dragon, et al.
Published: (2023-10-01)

Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires
by: Corinna Grunert, et al.
Published: (2022-04-01)

Harnessing Dendritic Cells for Tumor Antigen Presentation
by: Stefan Nierkens, et al.
Published: (2011-04-01)

In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy
by: Nicole J. Kim, et al.
Published: (2023-03-01)

Correlation Between Tumor Cell Differentiation and CEA Levels in Patients with Adenocarcinoma of the Rectum
by: Reno Rudiman, et al.
Published: (2020-12-01)

Prostate-Specific Membrane Antigen Expression in Neovasculature of Glioblastoma Multiforme
by: Parvin Mahzouni, et al.
Published: (2019-01-01)

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
by: Michal Bassani-Sternberg, et al.
Published: (2019-08-01)

Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?
by: Robert O. Dillman
Published: (2017-03-01)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
by: Sivan Seliktar-Ofir, et al.
Published: (2017-10-01)

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
by: Nadia Viborg, et al.
Published: (2019-12-01)

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
by: Christabelle Rajesh, et al.
Published: (2023-01-01)

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
by: Tuna Mutis, et al.
Published: (2020-06-01)

mRNA—From COVID-19 Treatment to Cancer Immunotherapy
by: Werner Krause
Published: (2023-01-01)

Editorial: Global excellence in translational immunology: Europe
by: Federica Casiraghi, et al.
Published: (2023-07-01)

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
by: Aurélie Durgeau, et al.
Published: (2018-01-01)